InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
无可用的信号评分。
Explore the complete record of transactions filed by 이권희, Directeur. Director active across 2 companies, notably 바이오포트. In total, 2 filings have been published. History available since 6 March 2026. The latest transaction was disclosed on 6 March 2026 (Purchase). Regulator: DART (FSS). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 条申报中的 2 条
Lee Kwon-hee is an Executive Director at Bioport, a company specializing in biotechnology. In this role, he oversees operations and contributes to the company's strategy. With his expertise, Lee plays a key role in the development and growth of the company.